Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 10 Dec 2025 for Adverum Biotechnologies, Inc..
Filing timeline
BuySaleRabia Gurses Ozden
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Rabia Gurses Ozden: trading record in brief
Filings by Rabia Gurses Ozden span 2 companies, the busiest being Ocular Therapeutix, Inc and Adverum Biotechnologies, Inc. We count 11 filings; the first trade dates from 1 July 2022 and the latest from 9 December 2025.
The open-market record consists of 4 sales worth €93k, with no purchase. Besides market trades, the filings include 5 share grants.
The latest filing, published on 10 December 2025, reports a transaction in Adverum Biotechnologies, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rabia Gurses Ozden
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
8,125 sharesCommon Stock - Restricted Stock UnitsSEC:0001814883-25-000005:0
8,125 shares0Common StockSEC:0001415889-25-005834:0
66,633 shares0Common StockSEC:0001104659-24-011197:0
7,764 shares@ US$4.9555.0% of flowCommon StockSEC:0001104659-24-010237:0
832 shares@ US$4.935.8% of flowCommon StockSEC:0001104659-23-080096:0
6,416 shares@ US$4.2439.1% of flowCommon StockSEC:0001104659-23-014685:0
55,556 shares0Common StockSEC:0001104659-23-009414:0
6,667 shares0Common StockSEC:0001104659-22-080288:0
8 of 8 declarations
